Caspases are essential in multicellular organisms for inducing cell death during normal development and in the immune system. However, caspases can also trigger the degenerative process under certain conditions such as pathophysiological conditions and aging. Here, we identified Semaphorin 7A (Sema7A) as a novel substrate for caspase-9 that can be used to monitor caspase-9 activity in mice, and found nonapoptotic caspase-9 activation in the aged olfactory bulb (OB). Immunostaining of the OB for the caspase-9-cleaved form of Sema7A revealed abundant caspase-9-activated cells in 2-year-old (aged) but not in 2-month-old (young) mice. In fact, various regions of the aged brain, including the OB, exhibited an increased level of caspase-9 activity. However, the number of dying cells in the aged OB was, intriguingly, much lower (Ͻ20%) than in the OB of young mice. Furthermore, we found that the lower number dying cells in the aged OB was accompanied by a decreased expression of procaspase-3. These results suggest a survival strategy for aged OB neurons, which can no longer regenerate, in which the central apoptotic machinery downstream of caspase-9 is inactivated.
Introduction
Programmed cell death is the essential process for eliminating superfluous or harmful cells in multicellular organisms (Jacobson et al., 1997) . The central players in apoptosis are a family of cysteine proteases called caspases (Miura and Yuan, 1996; Kumar, 2007) . Caspases are synthesized as precursor proteins, requiring specific processing for their activation. The processing of a caspase is elicited by its upstream caspase; thus, caspases comprise an activating protease cascade. Caspases are therefore divided into two classes: initiator caspases and effector caspases. The initiator caspases include caspases-2, -8, -9, -10, -11 in mammals and Dronc and Dredd in Drosophila, and the effector caspases include caspases-3, -6, and -7 in mammals and Drice and Dcp1 in Drosophila. The initiator caspase, caspase-9, is a crucial member of the family, essential for most cell deaths during normal development. However, recent studies in Drosophila suggest that the fly ortholog of caspase-9, Dronc, not only induces cell death but also regulates nonapoptotic processes, such as dendritic pruning of larval neurons, spermatid individualization, border cell migration, neural precursor development, and compensatory proliferation (Kumar, 2004; Kuranaga and Miura, 2007) . One mechanism by which caspases cause such nonapoptotic effects appears to be through the regulation of their activation threshold: in the same cell type, a low level of caspase activity or a localized activation of caspases leads to a nonapoptotic effect, but their strong activation results in apoptosis (Kuo et al., 2006; Kuranaga et al., 2006; Williams et al., 2006) . Thus, spatiotemporal regulation of the level of caspase activity may be crucial for multicellular organisms to maintain homeostasis.
Although caspase-dependent programmed cell death plays an essential role during normal development and tissue homeostasis, it can potentially induce undesirable cell deaths under certain conditions, such as pathological conditions and aging. Such unwanted cell deaths can be closely linked to neurodegeneration, stroke, traumatic brain injury, and aging. To avoid causing unwanted cell death, the activity of the caspase cascade must be tightly regulated. Activation of the caspase-9-dependent cascade is controlled by the mitochondrial release of cytochrome c. However, the molecular mechanism by which this cascade is regulated during normal development and aging is poorly understood. One reason for the lack of information is that caspase-9 activation in tissues is hard to detect due to its low enzymatic activity, even in dying cells. Here, we found that Sema7A is a unique substrate of caspase-9. Immunostaining by a commercially available affinitypurified Sema7A antibody (hereafter, we refer to it as the antiSema7A antibody) can be a sensitive detection method for caspase-9 activity in vivo. Using this novel method, we found nonapoptotic caspase-9 activation in the aged olfactory bulb (OB) of mice. We also found that caspase-3 expression was decreased in the aged OB compared with the young OB. The downregulation of caspase-3 expression could be a survival strategy by Sema7A was cleaved in a caspase-dependent manner. Whole-cell extracts were analyzed by immunoblotting using anti-Sema7A, anti-active-caspase-3, and anti-␤-tubulin antibodies. A, Apoptosis was induced in Neuro-2a cells by treatment with 250 nM STS or 50 M MG132 for 7 h, or by ectopically expressing reverse caspase-3 (rev-casp-3) or HA-BAX. zVAD-fmk (100 M) was added to inhibit caspase activation. B, Neuro-2a cells were transfected with either pcDNA3 or caspase-9 DN-pcDNA3 and then exposed to STS for 7 h. DEVD-CHO (100 M) was added to the cells 2 h before STS treatment. C, Neuro-2a cells were transfected with the indicated siRNA and incubated for 72 h, followed by exposure to STS for 5 h. Arrows and arrowheads show the caspase-dependent cleaved fragments of Sema7A.
which aged olfactory bulb neurons avoid caspase-9-triggered cell death signaling. It could also be a strategy for exerting nonapoptotic functions through the cleavage of axonal regulatory proteins, including Sema7A.
Materials and Methods
Mice. C57BL/6 mice were purchased from CLEA Japan. Twenty-fourmonth-old C57BL/6S mice were obtained from colonies maintained by the Tokyo Metropolitan Institute of Gerontology. apaf-1(ϩ/Ϫ) and apaf-1(Ϫ/Ϫ) mice were generated by interbreeding heterozygotes (Yoshida et al., 1998) . caspase-3 heterozygous (ϩ/Ϫ) mice backcrossed onto a C57BL/6 background for at least 10 generations were used to generate caspase-3 (Ϫ/Ϫ) mice (Kuida et al., 1996; Koike et al., 2008) . Methods for inducing proliferative cell death by cytosine arabinoside (Ara C) in embryonic mice have been described previously (Ohsawa et al., 2008a) .
Constructs. The vector encoding mouse Sema7A (Sema7A-pCMV-SPORT) was kindly provided by A. Yamada (Mine et al., 2000) . Sema7A cDNA was subcloned into the EcoRI/HindIII site of pBluescript SK (ϩ/Ϫ). The Sema7A mutants D231, 235, 236N; E181, 184G/D183G; and D245, 248G, were constructed by PCR mutagenesis using Sema7A-pBluescript as a template.
Immunohistochemistry. Mice were anesthetized deeply by pentobarbital and perfused through the ascending aorta with saline followed by 4% paraformaldehyde in 0.1 M PB, pH 7.3, for 15 min. The brains were removed and immersed in the same fixative for 2-3 h at 4°C. The tissues were immersed in 25% sucrose in 0.1 M PB at 4°C overnight. Tissues were then frozen quickly by hexane cooled with dry ice and 5 m sections were cut on a cryostat (Leica CM3050) and thaw-mounted on slides. We also used fresh frozen sections fixed by methanol for immunohistochemistry. Mice were anesthetized deeply and decapitated. The brains were removed rapidly and immersed in embedding material (OCT compound; Miles) . The brains were quickly frozen by hexane cooled with dry ice. The fresh-frozen sections were then cut on a cryostat and thaw-mounted on slides. Before immunohistochemical procedures, sections were fixed by cold methanol for 15 min. These two methods gave essentially the same results.
The staining method used for immunohistochemistry has been described previously (Ohsawa et al., 2005) . The following antibodies were used at the indicated dilutions: rabbit monoclonal anti-active caspase-3 C92-605 (BD; 1:1000), rabbit polyclonal anti-Sema7A (Abcam; 1:100), mouse monoclonal anti-PSA-NCAM (kindly provided by T. Seki; 1:500) (Seki and Arai, 1991) , and rabbit polyclonal anti-cleaved caspase-9 (Asp353) (Cell Signaling Technologies; 1:100). The TUNEL assay (In Situ Cell Death Detection kit; Roche) was performed according to the manufacturer's instructions.
Cells, transfection, immunostaining, preparation of cell lysates, and immunoblotting. Neuro-2a cells were cultured in DMEM containing 10% fetal bovine serum and 2 mM L-glutamine. Cells were transfected using Lipofectamine 2000 reagent (Invitrogen BRL) following the manufacturer's instructions. The methods used for immunostaining and immunoblotting have been described previously (Ohsawa et al., 2008a) . The following antibodies were used at the indicated dilutions: rabbit monoclonal antiactive caspase-3 C92-605 (BD; 1:1000), rabbit polyclonal Sema7A (Abcam; 1:500), mouse monoclonal caspase-9 (MBL; 1:1000), mouse monoclonal caspase-3 antibody C92-605 (BD; 1:1000), mouse monoclonal cleaved PARP 7C9 (Cell Signaling Technologies; 1:1000), mouse monoclonal anti-H1 clone AE-4 (Upstate; 1:200), and mouse monoclonal anti-␤-tubulin (Millipore Bioscience Research Reagents; 1:1000). Caspase activity assays. Cytoplasmic extracts of young and aged brains were prepared for caspase activity assays as described previously (Kanuka et al., 1999) , with several modifications. Mouse tissues were dissected, immediately frozen in liquid nitrogen, and stored at Ϫ80°C. Suspension buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 10 mM EGTA, and 10 M digitonin) was added to tissues, then mixtures were voltexed and incubated for 10 min at 37°C, and then cell lysates were cleared by centrifugation. Cell lysates containing 4 g of protein were mixed with an equal volume of assay buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 0.05% NP40, and 5 mM MgCl 2 ) and preincubated at 37°C for 30 min. Assay buffer (1 ml) containing 10 M enzyme substrate Ac-YVAD-MCA, Ac-DEVD-MCA, Ac-IETD-MCA, or Ac-LEHD-MCA (Peptide Institute, Osaka) was added to the lysate, and the mixture was incubated at 37°C for 30 min. The level of released 7-amino-4-methylcoumarin was measured using a spectrofluorometer (Biolumin 960, Molecular Dynamics) with excitation at 380 nm and emission at 460 nm. Activity was expressed in picomoles of 7-amino-4-methylcoumarin generated. The data were collected from three independent experiments and are presented as the mean Ϯ SD.
RNA interference in Neuro-2a cells. Neuro-2a cells were transfected with the siRNA for Sema7A (Invitrogen; target sequence ACUUGUGUA-CAGUUCACUCUCGCCC or GGGCGAGAGUGAACUGUACACAAGU) and a control siRNA [Qiagen; target sequence AATTCTCCGAACGTGT-CACGT or the siRNA for LacZ generated by a BLOCK-iT RNAi TOPO Transcription Kit (Invitrogen)] by use of the Lipofectamine 2000 reagent (Invitrogen) following the manufacturer's instructions. Seventy-two hours after the transfection, the cells were exposed to 250 nM staurosporine (STS), followed by immunostaining or immunoblotting as described above.
In vitro cleavage of Sema7A. The in vitro cleavage assay was performed as described previously (Takemoto et al., 2003) . Sema7A protein was prepared by in vitro transcription and translation using a TNT-coupled reticulocyte lysate system (Promega). Wild-type or mutant Sema7A (2 l) was incubated at 37°C in 20 l of reaction mixture with 1 U purified active caspase-1, -3, -6, -8, or -9 (MBL) for 2 or 4 h. The buffer for the reaction mixture contained 20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 2 g/ml aprotinin, and 5 g/ml pepstatin A. In vitro cleavage analysis of Sema7A. A, B, Sema7A synthesized in vitro was cleaved by 1 U of purified activated caspase-1, -3, -6, -8, or -9 in a 2 h incubation. As a control, DMSO was used instead of purified activated caspases. The reaction mixture was then subjected to immunoblot analysis using the anti-Sema7A antibody. C, Schematic of mouse Sema7A. The signal sequence and GPI anchor motif are indicated by a pink and a blue box, respectively. The integrin-binding motif, RGD, is indicated by an asterisk. The possible cleavage site for caspase-9 was within the VHQD(231)QAYD(235)D(236) motif in Sema7A. D, Cleavage assay for wild-type (WT) and the indicated mutant Sema7A using purified activated caspase-3 (3) or caspase-9 (9). The mutation of Asp (D) 231, 235, 236 to Asn (N) in Sema7A strongly inhibited its cleavage by caspase-9. Arrows show the cleaved fragment of Sema7A. C, DMSO.
Results

An antibody against Sema7A preferentially immunolabeled caspase-dependent apoptotic cells
Sema7A is a membrane-anchored member of the semaphorin family of guidance proteins, known for its effects on axonal growth in the nervous system and its diverse functions in the immune system (Suzuki et al., 2007) . A deficiency of Sema7A in mice impairs the formation of the lateral olfactory tract, which is a caudally extending fiber bundle from mitral cells in the OB (Pasterkamp et al., 2003) . The overexpression of Sema7A enhances the neurite outgrowth of cultured neural cells, including olfactory sensory neurons (OSNs), cortical neurons, and thalamic neurons Maruyama et al., 2008) . Intriguingly, we found that a rabbit polyclonal antibody against amino acid residues 1-100 of mouse Sema7A strongly immunolabeled olfactory sensory axons projecting to the anterior-medial and posterior-ventral regions of the olfactory bulb, a region where caspase-3 is strongly activated (supplemental Fig. 2C , available at www.jneurosci.orgassupplemental material; unpublished data). apaf-1 or caspase-9 deficiency abolished the immunoreactivity of both anti-active-caspase-3 and antiSema7A antibodies in the olfactory sensory axons. Thus, there appeared to be a relationship between Sema7A and caspase activity in neurons.
To analyze this relationship in detail, we used the mouse neuroblastoma cell line Neuro-2a (Fig. 1) . Immunofluorescent labeling of Neuro-2a cells revealed that the anti-Sema7A antibody failed to recognize healthy cells, even though these cells expressed Sema7A (Fig. 1 A, 2A) . In contrast, this antibody labeled STS-treated cells (hereafter, "Sema7A-positive" cells) that were undergoing caspase-dependent cell death, which was characterized by the loss of AE-4 anti-H1 immunoreactivity (Ohsawa et al., 2008a) (Fig. 1 A) . Treatment of the Neuro-2a cells with the pan-caspase inhibitor zVAD-fmk suppressed not only the STS-induced cell death but also the immunoreactivity of these cells with the anti-Sema7A antibody (Fig. 1 B) . In contrast, an inhibitor of caspase-3-like proteases, Ac-DEVD-CHO, failed to suppress the labeling for Sema7A in STS-treated Neuro-2a cells, suggesting that a non-DEVDase activity is involved in the Sema7A immunoreactivity (Fig. 1B,C) . Furthermore, the siRNAmediated knock-down of Sema7A in Neuro-2a cells abolished their immunoreactivity with the anti-Sema7A antibody, indicating that this antibody indeed recognized Sema7A (Fig. 1A) . These data suggest that the anti-Sema7A antibody recognizes Sema7A specifically in cells undergoing caspase-dependent cell death.
Caspase-9-dependent cleavage of Sema7A during apoptosis
The Sema7A protein contains a glycosylphosphatidylinositol (GPI)-anchored motif and several putative N-linked glycosylation sites. In Western blot analysis, the anti-Sema7A antibody detects three types of Sema7A (of ϳ100, 75, and 50 kDa) in healthy Neuro-2a cells, all of which are abrogated by preincubation of the antibody with the immunizing peptide, according to the information provided by Abcam. We observed the same three Sema7A bands, which were abolished by the siRNA knockdown of Sema7A (Fig. 2C) .
To investigate the molecular nature of the Sema7A in dying cells, Neuro-2a cells were treated with STS or MG132 (Fig. 2 A) . Endogenous Sema7A was cleaved in response to these apoptotic stimuli (Fig. 2, arrow and arrowhead) . The same cleavage pattern was observed when autocatalytic reverse caspase-3 (Suzuki et al., 2001) or proapoptotic HA-BAX was overexpressed in Neuro-2a cells (Fig. 2 A) . Since activated caspase-3 cleaves caspase 9 in a positive-feedback loop (Srinivasula et al., 1998; Slee et al., 1999; Srinivasula et al., 2001 ), the expression of reverse caspase-3 would be expected to activate initiator caspase-9. The pancaspase inhibitor zVAD, as well as caspase-9 DN, inhibited the processing of Sema7A (Fig. 2 B) . Furthermore, pretreatment with a caspase-3 inhibitor, Ac-DEVD-CHO, had only subtle effects on the cleavage of Sema7A (Fig. 2 B) , suggesting that this antibody specifically detects the caspase-9-cleaved form of Sema7A. Furthermore, Western blot analysis of Sema7A-knock-down cells ) were prepared from apaf-1 heterozygous and homozygous embryos that had been treated with Ara C to induce apoptosis, and then the sections were stained with the anti-Sema7A antibody (green). Nuclei were stained with propidium iodide (PI) (magenta). Scale bar, 50 m. The arrows show pyknotic cells. B, Wholecell extracts (30 g) of untreated or Ara C-treated forebrain of C57B6J mice were analyzed by immunoblotting using anti-Sema7A and anti-active-caspase-3 antibodies. C, Whole-cell extracts of Ara C-treated forebrain from wild-type, apaf-1 (ϩ/Ϫ), and apaf-1 (Ϫ/Ϫ) mice were analyzed as described in B. Arrows and arrowheads in B and C show the caspase-dependent cleaved fragment of Sema7A.
confirmed that the STS-induced fragments were indeed derived from Sema7A (Fig. 2C) . These data suggest that Sema7A is cleaved by active caspase-9, but not by active caspase-3, in dying cells.
Sema7A is a direct substrate of caspase-9
To examine whether caspases could directly cleave Sema7A, recombinant Sema7A protein was digested with purified active-caspase-1, -3, -6, -8, or -9 in vitro. Incubation of Sema7A protein with caspase-9 resulted in the appearance of a cleavage fragment migrating at 24 kDa (Fig. 3A,B) . The different size of this cleavage fragment relative to those obtained from cultured Neuro-2a cells might be because of the lack of post-translational modification in the in vitro-translated Sema7A. We mapped the site cleaved by caspase-9 by constructing mutant Sema7A proteins for putative caspase-cleaved sites (Thornberry et al., 1997) . Mutations of Asp231, 235, and 236 to Asn (VHQDQAYDD3 VHQNQAYNN) in Sema7A blocked the cleavage by caspase-9 (Fig. 3C) . A single mutation of Asp231 to Gly in Sema7A also largely blocked its cleavage by caspase-9 (supplemental Fig. 1A , available at www.jneurosci.org as supplemental material). In contrast, other putative cleavage site mutations, including E181D, E184G, D183G, D245G, and D248G, failed to block the cleavage by caspase-9 (supplemental Fig. 1B , available at www.jneurosci.org as supplemental material). These data suggest that the VHQDQAYDD motif in Sema7A, which is evolutionarily conserved among human, mouse, and rat, is the likely cleavage site for caspase-9.
Apaf-1-dependent cleavage of Sema7A and the appearance of Sema7A-positive cells among genotoxin-induced dying cells in the mouse embryo To examine whether Sema7A undergoes caspase-dependent changes during apoptosis in vivo, we compared the staining patterns of the Sema7A antibody in wild-type and apaf-1-mutant mice, which are deficient for caspase activation (Yoshida et al., 1998) . Apaf-1 is essential for the activation of caspase-9 and is required for the induction of apoptosis by the DNA-damaging reagent Ara C) in neural precursor cells of the embryonic cortex (D'Sa et al., 2003) . We observed a number of dying cells with condensed nuclei in the ventricular zone of Ara C-treated apaf-1 (Ϫ/ϩ) embryos (Fig. 4A) . Consistent with our in vitro data, these cells were specifically stained with the Sema7A antibody. In contrast, apaf-1-deficient homozygous embryos were resistant to the Ara C-induced cell death, and were not stained with the Sema7A antibody, with the exception of few pyknotic cells (Ohsawa et al., 2008a) , indicating that the anti-Sema7A antibody specifically immunolabeled Apaf-1-dependent apoptotic cells (Fig. 4 A) . Furthermore, immunoblotting confirmed the results of this immunofluorescence analysis (Fig. 4 B, C) . These data suggest that Sema7A is cleaved in a caspase-dependent manner in vivo and can be used to detect caspase-dependent apoptosis in mice. Positive-feedback activation of caspase-9 by caspase-3 in Ara C-treated embryonic brain Caspase-3 is known to function downstream of caspase-9. Caspase-9 activation was observed in ␥-irradiated caspase-3 (Ϫ/Ϫ) neural precursor cells in vitro (D'Sa et al., 2003) . On the other hand, previous studies have also suggested that activated caspase-3 is required for the processing and complete activation of caspase-9 (Srinivasula et al., 1998 (Srinivasula et al., , 2001 Slee et al., 1999; Fujita et al., 2001) . However, little is known about the significance of caspase-3 activity in caspase-9 activation in vivo. We thus examined whether caspase-9 is activated and cleaves its substrates in response to DNA damage in the ventricular zone of caspase-3 (Ϫ/Ϫ) embryos. Caspase-3-deficient homozygous embryos were resistant to Ara C-induced cell death in the ventricular zone of the embryonic cortex, which is consistent with the previous report (D 'Sa-Eipper et al., 2001) . Intriguingly, we found that almost all cells were not stained with a commercially available anti-cleaved mouse caspase-9 (Asp353) and the Sema7A antibody, with the exception of few pyknotic cells (supplemental Fig. 2 , available at www. jneurosci.org as supplemental material), suggesting that caspase-3 activity induced caspase-9 activation and following cleavage of Sema7A in a positive-feedback loop in Ara C-treated embryonic brain. Furthermore, we also examined whether caspase-3 activity is required for the cleavage of Sema7A in the developing olfactory system. Anti-active-caspase-3 and the Sema7A antibodies immunolabeled the olfactory sensory axons projecting to the anterior-medial and posterior-ventral regions of the olfactory nerve layer in caspase-3 (ϩ/Ϫ) OB (supplemental Fig. 2C , available at www. jneurosci.org as supplemental material; unpublished data). In contrast, caspase-3 deficiency abolished the immunoreactivity of not only anti-active-caspase-3 but also anti-Sema7A antibodies in the olfactory sensory axons (supplemental Fig. 2C , available at www. jneurosci.org as supplemental material). These data suggest that the feedback activation of caspase-9 by caspase-3 also functions in the normal development of the olfactory system. Caspase-9 activation in the aged OB We next applied the Sema7A antibody staining technique to the analysis of cell death regulation in aged olfactory neurons in mice. Olfactory defects are common in human aging (Doty et al., 1984; Cain and Stevens, 1989) . The adult OB retains the potential to regenerate new olfactory neurons, which counters the age-dependent olfactory defects (Kempermann et al., 2004) . Although cell death plays an important role in regulating neurogenesis by eliminating old olfactory neurons in the OB, the age-related changes in cell death and caspase signaling in these cells have remained unknown.
We therefore analyzed the OB in 2-month-old (young) and 2-year-old (aged) mice by Sema7A antibody staining (Fig. 5A-C) . Sema7A-positive cells were observed in the granule cell layer (GCL) (Fig. 5C ) and the glomerular layer (Fig. 5B) of the aged OB. However, only a few cells were immunolabeled with the anti-Sema7A antibody in the young OB (Fig. 5A) . Although myelin loss and damage have been observed in the aged mouse brain (Bartzokis, 2004) , the anti-Sema7A antibody failed to stain O4-positive oligodendrocytes. Immunoblotting confirmed the results of the staining analysis, revealing that Sema7A was cleaved in the aged OB (Fig. 5D) .
We also measured caspase activity in young and aged neural tissues by using different caspase substrates, including Ac-YVAD-MCA (for caspase-1-like proteases), Ac-DEVD-MCA (caspase-3-like proteases), Ac-IETD-MCA (caspase-8-like proteases), and Ac-LEHD-MCA (caspase-9-like proteases). We found that the caspase-9-like LEHD-cleaving activity was dramatically increased in the aged brain, while the YVAD-, DEVD-, and IETD-cleaving activities had not changed, suggesting that caspase-9 was specifically activated with aging (Fig. 6) .
Intriguingly, no caspase-3 activation or caspase-3-dependent cleavage of PARP was observed in the aged OB, even though these cells had increased caspase-9 activation (Fig. 6B,D, 7B ). Double staining of the OB for activated caspase-3 and DNA fragmentation showed that the number of TUNEL-positive, active-caspase-3-positive, and TUNEL-positive/active-caspase-3-positive cells decreased in the aged OB, consistent with a previous report (Mirich et al., 2002) (Fig. 7A) . We also found that the numbers of PSA-NCAMpositive immature neurons Arai, 1991, 1993) were dramatically lower than in the young OB, indicating that neurogenesis had also decreased in the aged OB (young OB: 62.9 Ϯ 8.85 cells/mm 2 OB; aged OB: 1.93 Ϯ 1.16 cells/mm 2 OB; values are the mean Ϯ SEM; n ϭ 3; t test; p Ͻ 0.01) (Fig. 7C ). These observations indicate that the activation of initiator caspase-9 signaling is not always associated with downstream caspase-3 activation in the aged brain. To keep olfactory cells alive in the aged OB, which has reduced neurogenesis, a system for avoiding apoptotic cell death might be activated. To address the mechanism for this system, we examined the expression level of the procaspase-3 zymogen (Fig. 7B ) and found that it was dramatically decreased in the aged OB. Together, these observations suggest that the downregulation of procaspase-3 expression is a strategy used by aged OB neurons to survive under Evolution of cells' transition from sensitivity to resistance to apoptotic stimuli In aged mice, caspase-9 activity failed to induce apoptotic cell death. Our data indicate that this interesting phenomenon was due to a significant reduction in the amount of the procaspase-3 zymogen in the aged OB, which might be insufficient to execute the cell death pathway. Interestingly, a similar idea was recently proposed in a study showing that epigenetic inactivation of the proapoptotic reaper and hid genes reduces the cell sensitivity to cytotoxic stimuli during Drosophila embryogenesis; proliferating cells in Drosophila embryos are highly sensitive to gamma-rayinduced apoptosis at early stages, but later become resistant to this stimulus in differentiating cells. Thus, the transition from sensitivity to resistance to apoptotic stimuli might have emerged in developmental processes and then been adopted by nervous systems in long-living animals through evolution.
